SAS#19 Flashcards

1
Q

Lower serum levels of cholesterol and various lipids. They are also called as lipid-lowering agents

A

ANTIHYPERLIPIDEMIC DRUGS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

C a d is the leading cause of death worldwide and its incidence is highly and people with

A

HYPERLIPIDEMIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

These drugs are used to normalize high serum levels of cholesterol

A

BILE ACID SEQUESTRANTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Exert their effect in the intestine by binding into bile acids which contain a high level of cholesterol

A

BILE ACID SEQUESTRANTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Is also used to treat pruritus associated with partial biliary obstruction

A

CHOLESTYRAMINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

this drug group increases the cell absorption of ldl by blocking the enzyme regulating the rate-limiting step in the synthesis of cholesterol

A

HMG CoA REDUCTASE INHIBITORS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Block the completion of cholesterol synthesis in the body

A

HMG Coa reductase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Are indicated for patients with documented c a d to slow progression of the disease

A

PRAVASTATIN
LOVASTATIN
SIMVASTATIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pravastatin lovastatin and simvastatin, together with this three agents _____ is used as prophylaxis for first myocardial infarction attack for patients with multiple risk factors for c a d

A

ATORVASTATIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Is the drug of choice for patients who have multiple risk factor or have already develop c a d

A

HMG-COA REDUCTASE INHIBITOR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

This class is well tolerated and is less expensive compared to other classes with the same therapeutic effect

A

HMG-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Increased serum levels and resultant of hmg-coa reductase inhibitors

A

DIGOXIN
WARFARIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Atorvastatin can be given at

A

ANY HOUR OF THE DAY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

administered drug at bedtime to maximize effectiveness of the drugs because pic of cholesterol synthesis is from midnight to 5:00 a.m.

A

HMG COA REDUCTASE INHIBITOR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Are one of the new class of drug approved to lower serum cholesterol levels

A

CHOLESTEROL ABSORPTION INHIBITOR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Acting on the brush border of intestine,_____block the absorption of dietary cholesterol

A

CHOLESTEROL ABSORPTION INHIBITOR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Increased toxicity of cholesterol absorption inhibitors

A

CYCLOSPORINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Increased risk for development of cholelithiasis

A

FIBRATES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Altering the formation of platelet plug

A

ANTIPLATELET DRUG

20
Q

Altering interfering the clotting cascade and thrombin formation

A

ANTICOAGULANT DRUGS

21
Q

Altering the stimulating of the plasmin system to break down the formed class

A

THROMBOLYTIC AGENTS

22
Q

DisOrders that directly affect coagulation process

A

THROMBOEMBOLIC DISORDERS
HEMORRHAGIC DISORDERS

23
Q

Which involve overproduction of clots

A

THROMBOEMBOLIC DISORDERS

24
Q

Which is characterized by ineffective clotting process leading to excessive bleeding

A

HEMORRHAGIC DISORDERS

25
Include medical conditions which involve overproduction of clots which result in to decrease blood flow and total vessel occlusion
THROMBOEMBOLIC DISORDERS
26
Conditions under hemorrhagic disorders
HEMOPHILIA LIVER DISEASE BONE MARROW DISORDERS
27
Characterized by genetic lack of clotting factors
HEMOPHILIA
28
Characterized by non production of proteins and clotting factors necessary for clot formation
LIVER DISEASE
29
Characterized by in sufficient quantity of platelets rendering them ineffective
BONE MARROW DISORDERS
30
THROMBOEMBOLIC disorders manifestations include
Hypoxia Anoxia Necrosis
31
This drug class exerts action by decreasing the responsiveness of platelets to stimuli that cause it to clump or aggregate
ANTIPLATELET AGENTS
32
Blocks the production of platelets in the bone marrow
ANAGRELIDE
33
Increase risk of bleeding if combined with another drug that affects blood clotting
ANTIPLATELET ANGENTS
34
By interfering with clotting cascade and thrombin formation_____are able to interfere with the normal clotting process
ANTICOAGULANT
35
Two new oral agents, directly inhibits thrombin and factor xa respectively
DABIGATRAN RIVAROXABAN
36
Is used for prevention of blood clots in blood samples dialysis and venus tubing. It also does not enter breast milk so it is the anticoagulant of choice for lactating women
HEPARIN
37
Block formation of thrombin from prothrombin
HEPARIN AND ANTITHROMBIN
38
Antidote of heparin
PROTAMINE SULFATE
39
Antidote of warfarin
VITAMIN K
40
Blood test for warfarin
PROTHROMBIN TIME (PT) INTERNATIONAL NORMALIZED RATIO(INR)
41
Blood test for heparin
WHITE BLOOD CLOTTING TIME ACTIVATED PARTIAL THROMBOPLASTIN TIME
42
Promote clot resolution,the process of activating the plasmin system to break down the thrombus or clot that has been form
THROMBOLYTIC AGENTS
43
Increased risk of bleeding when interaction with thrombolytic agents
ANTICOAGULANT AND ANTIPLATELET
44
Evaluate the ability to clot
PT
45
Blood thinning effect
PTT (60-70 SEC)
46
How many seconds in APTT
30-40